Page last updated: 2024-09-04

naproxen and Dyslipidemia

naproxen has been researched along with Dyslipidemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alnouti, Y; Desouza, CV; Heineman, R; Saraswathi, V; Shivaswamy, V	1

Trials

1 trial(s) available for naproxen and Dyslipidemia

Article	Year
A combination of Omega-3 PUFAs and COX inhibitors: A novel strategy to manage obesity-linked dyslipidemia and adipose tissue inflammation. Journal of diabetes and its complications, 2020, Volume: 34, Issue:2 Topics: Adipose Tissue; Adult; Biopsy; Cyclooxygenase Inhibitors; Dyslipidemias; Fatty Acids, Omega-3; Female; Fish Oils; Humans; Inflammation; Male; Middle Aged; Naproxen; Obesity; Overweight; Pilot Projects; Prospective Studies; Triglycerides	2020

Article

Year

A combination of Omega-3 PUFAs and COX inhibitors: A novel strategy to manage obesity-linked dyslipidemia and adipose tissue inflammation.

Journal of diabetes and its complications, 2020, Volume: 34, Issue:2

Topics: Adipose Tissue; Adult; Biopsy; Cyclooxygenase Inhibitors; Dyslipidemias; Fatty Acids, Omega-3; Female; Fish Oils; Humans; Inflammation; Male; Middle Aged; Naproxen; Obesity; Overweight; Pilot Projects; Prospective Studies; Triglycerides

2020